Bacteremia Caused by Escherichia coli producing Extended-spectrum Beta-lactamase: a Case-control Study of Risk Factors and Outcomes

References

• Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999; 29: 595–607.
   PubMed Web of Science ®Google Scholar
• NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th edn. Wayne, PA: NCCLS, 2000.
   Google Scholar
• Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35: 2061–7.
   PubMed Web of Science ®Google Scholar
• Jones RN, Jenkins SG, Hoban DJ, Pfaller MA, Ramphal R. In vitro efficacy of six cephalosporins tested against Enter- obacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997–1998. Int J Antimicrob Agents 2000; 15: 111–8.
   Google Scholar
• Public Health Laboratory Service. Surveillance of hospital-acquired bacteraemia. http://www.phls.co.uk/publications/in-dex.htm. Last accessed 1 March, 2001.
   Google Scholar
• Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174: 529–36.
   PubMed Web of Science ®Google Scholar
• Wong-Beringer A, Lee NP, Hindler J, Pegues A. Treatment outcome of extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. In: Program and abstract of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ont., Canada, 1997. Washington, D.C.: American Society for Microbiology, 1997: 289 (Abstract J–8).
   Google Scholar
• McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 2001; 110: 847–55.
   Google Scholar
• Siau H, Yuen KY, Ho PL, Wong SS, Woo PC. Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis 1999; 28: 26–30.
   Google Scholar
• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/ SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–55.
   Google Scholar
• Ho PL, Tsang DN, Que TL, Ho M, Yuen KY. Comparison of screening methods for detection of extended-spectrum betalactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. APMIS 2000; 108: 237–40.
   Google Scholar
• Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584–602.
   PubMed Web of Science ®Google Scholar
• Gransden WR, Eykyn SJ, Phillips I, Rowe B. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev Infect Dis 1990; 12: 1008–18.
   PubMedGoogle Scholar
• Gikas A, Samonis G, Christidou A, Papadakis J, Kofteridis D, Tselentis Y, et al. Gram-negative bacteremia in non-neu- tropenic patients: a 3-year review. Infection 1998; 26: 155–9.
   PubMed Web of Science ®Google Scholar
• Kuikka A, Sivonen A, Emelianova A, Valtonen VV. Prognostic factors associated with improved outcome of Escherichia coli bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis 1997; 16: 125–34.
   PubMedGoogle Scholar
• Karas JA, Pillay DG, Muckart D, Sturm AW. Treatment failure due to extended spectrum beta-lactamase. J Antimicrob Chemother 1996; 37: 203–4.
   PubMed Web of Science ®Google Scholar
• Caron F, Gutmann L, Bure A, Pangon B, Vallois JM, Pechinot A, et al. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase. Antimicrob Agents Chemother 1990; 34: 2070–4.
   PubMedGoogle Scholar
• Fantin B, Pangon B, Potel G, Caron F, Vallee E, Vallois JM, et al. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Antimicrob Agents Chemother 1990; 34: 581–6.
   PubMed Web of Science ®Google Scholar
• Rice LB, Yao JD, Klimm K, Eliopoulos GM, Moellering RCJ. Efficacy of different beta-lactams against an extended- spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob Agents Chemother 1991; 35: 1243–4.
   Google Scholar
• Lucet JC, Chevret S, Decre D, Vanjak D, Macrez A, Bedos JP, et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22: 430–6.
   PubMed Web of Science ®Google Scholar
• De Champs C, Rouby D, Guelon D, Sirot J, Sirot D, Beytout D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991; 18: 5–13.
   PubMed Web of Science ®Google Scholar
• Decre D, Gachot B, Lucet JC, Arlet G, Bergogne BE, Regnier B. Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 1998; 27: 834–44.
   PubMedGoogle Scholar
• Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517–23.
   PubMed Web of Science ®Google Scholar
• Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998. J Antimicrob Chemother 2000; 45: 183–9.
   Google Scholar
• Cormican MG, Marshall SA, Jones RN. Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen. J Clin Microbiol 1996; 34: 1880–4.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409–24.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30: 473–8.
   Google Scholar
• Martinez ML, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998; 351: 797–9.
   Google Scholar